Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: Comparison with cystadenomas and overt carcinomas

Histopathology

Volumn 32, Issue 2, 1998, Pages 151-159

  Darai, E ^a   Walker Combrouze, F ^a   Fauconnier, A ^a   Madelenat, P ^a   Potet, F ^a   Scoazec, J Y ^b  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Adhesion molecules; Borderline ovarian tumours; CD44; Cell proliferation; Ovarian cancer; p53 protein

Indexed keywords

HERMES ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CYSTADENOMA; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; TUMOR CLASSIFICATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; CADHERINS; CARCINOMA; CELL DIVISION; CYSTADENOMA, MUCINOUS; CYSTADENOMA, SEROUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031930427     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00347.x     Document Type: Article

References (34)

1. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 1992: 89; 12160-12165.
2. Tolg C, Hofmann M, Herrlich P, Ponta H. Splicing choice from ten exons establishes CD44 variability. Nucl. Acids Res. 1993: 21; 1225-1229.
3. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 1991: 10; 343-348.
4. Mackay GR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variants isoforms in humans. J. Cell Biol. 1994: 124; 71-82.
5. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J. Biol. Chem. 1992: 267; 4732-4739.
6. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992: 340; 1053-1058.
7. Fox SB, Gatter KC, Jackson DG et al. CD44 and cancer screening. Lancet 1993: 342; 548-549.
8. Günthert U, Hoffman M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991: 65; 13-24.
9. Heider K-H, Hofmann M, Hors E et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol. 1993: 120; 227-233.
10. Rudy W, Hofmann M, Schwartz Albiez R et al. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res. 1993: 53; 1262-1268.
11. Cannistra SA, Kansas GS, Niloff J, De Franzo B, Kim Y, Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res. 1993: 53; 3830-3838.
12. Jones LM, Gardner MJ, Gatterall JB, Turner GA. Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin. Exp. Metastasis 1995: 13; 373-380.
13. Gardner MJ, Jones LM, Catterall JB, Turner GA. Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett. 1995: 91; 229-234.
14. Gardner MJ, Catterall JB, Jones LM, Turner GA. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis. Clin. Exp. Metastasis 1996: 14; 325-334.
15. Strobel T, Swanson L, Cannistra SA. In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation. Cancer Res. 1997: 57; 1228-1232.
16. Uhl-Steidl M, Müller-Holzner E, Zeimet AG et al. Prognostic value of CD44 splice variant expression in ovarian cancer. Oncology 1995: 52; 400-406.
17. Cannistra SA, Abu-Jawdeh G, Niloff J et al. CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. J. Clin. Oncol. 1995: 13; 1912-1921.
18. Sliutz G, Tempfer C, Winkler S, Kohlberger P, Reinthaller A, Kainz C. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br. J. Cancer 1995: 72; 1494-1497.
19. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer 1973: 31; 1031-1045.
20. Nikrui N. Survey of clinical behavior of patients with borderline epithelial tumors of the ovary. Gynecol. Oncol 1981: 12; 107-119.
21. Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy: a clinical and pathological study of 108 cases. Cancer 1986: 58; 2052-2065.
22. Kupryjanczyk J, Bell DA, Yandell DW, Scully RE, Thor AD. p53 expression in ovarian borderline tumors and stage I carcinomas. Am. J. Clin. Pathol. 1994: 102; 671-676.
23. Klemi PJ, Takahashi S, Joensuu H, Kiilholma P, Narimatsu E, Mori M. Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors. Int. J. Gynecol. Pathol. 1994: 13; 228-233.
24. Daraï E, Scoazec J-Y, Walker-Combrouze F et al. Expression of cadherins in benign, borderline and malignant epithelial tumors of the ovary. Human Pathol. 1997: 28; 922-928.
25. Oncology Committee of the International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics. Am. J. Obstet. Gynecol. 1987: 156; 263-264.
26. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed. paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 1991: 39; 741-748.
27. Graham RC Jr, Karnovskv MJ. The early stages of absorption of horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J. Histochem. Cytochem. 1966: 14; 291-298.
28. Penno MB, August JT, Baylin SB et al Expression of CD44 in human lung tumors. Cancer Res. 1994: 54; 1381-1387.
29. Rove GD, Myers RB, Brown D, Poczatek R, Beenken SW, Grizzle WE. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int. J. Cancer (Pred. Oncol.) 1996: 69; 254-258.
30. Dall P, Hekele A, Ikenberg H et al. Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis. Int. J. Cancer (Pred. Oncol.) 1996: 69; 79-85.
31. Abbasi AM, Chester KA, Talbot IC et al. CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur. J. Cancer 1993: 29A; 1995-2002.
32. Furuta K, Zahurak M, Yang X-L et al. Relationship between CD44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms. Am. J. Pathol. 1996: 149; 1147-1155.
33. Penneys NS. CD44 expression in normal and inflamed skin. J. Cutan. Pathol. 1993: 20; 250-253.
34. Seelentag WKF, Günthert U, Saremaslani P et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int. J. Cancer (Pred. Oncol.) 1996: 69; 218-224.